M2 Pharma - Therapy Areas

JanOne names new interim president of JanOne Biotech subsidiary

24 March 2023 - JanOne (Nasdaq: JAN), a US-based biopharmaceutical company, announced on Thursday that it has named John N Bonfiglio, PhD, as interim president of its JanOne Biotech subsidiary.Dr Bonf...

United States Specialty Generics Market to Reach USD 43.1bn by 2027, According to Research and Markets

14 March 2023 - - The "United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to Dublin-based...

Estrella Biopharma and TradeUP Acquisition receives US FDA approval for EB103 IND application

9 March 2023 - US-based Estrella Biopharma, Inc., a biopharmaceutical company, and TradeUP Acquisition Corp. (NASDAQ:UTPD), a special purpose acquisition company formed for the purpose of effecting a ...

LinKinVax Touts Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate

23 February 2023 - - France-based clinical-stage biotechnology company LinKinVax has received the interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine and conducted by t...

US Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

23 February 2023 - - US-based pharmaceutical company Merck (NYSE: MRK) has opened enrollment in its new Phase 3 clinical program with investigational once-daily islatravir 0.25 mg in combination with ...

Maternova, MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis

21 February 2023 - - US-based maternal and infant health company Maternova, Inc and Canada-based rapid diagnostics developer MedMira Inc. (TSX Venture: MIR) have entered into a multinational...